Raymond J Cho Selected Research

APOBEC Deaminases

4/2021	Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
1/2018	APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond J Cho Research Topics

Disease

7	Neoplasms (Cancer) 04/2021 - 03/2012
3	Inflammation (Inflammations) 10/2020 - 10/2018
2	Skin Diseases (Skin Disease) 01/2022 - 03/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014 - 10/2011
1	Exanthema (Rash) 01/2022
1	Dermatitis 10/2020
1	Teratoma (Teratoid Tumor) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Breast Neoplasms (Breast Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	APOBEC DeaminasesIBA 04/2021 - 01/2018
1	Complex MixturesIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Cytosine DeaminaseIBA 04/2021
1	PolynucleotidesIBA 04/2021
1	OxazoloneIBA 10/2020
1	Imiquimod (Aldara)FDA LinkGeneric 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	HeterochromatinIBA 11/2014
1	ChromatinIBA 11/2014
1	Viral DNAIBA 07/2014
1	Biological ProductsIBA 01/2013
1	ParaffinIBA 01/2013
1	Histones (Histone)IBA 03/2012
1	Notch ReceptorsIBA 10/2011

Therapy/Procedure

2	Therapeutics 09/2015 - 03/2012